Impact of HIV genotyping and drug levels on the response to salvage therapy with saquinavir/ritonavir

AIDS. 2002 Sep 27;16(14):1964-6. doi: 10.1097/00002030-200209270-00016.
No abstract available

MeSH terms

  • CD4 Lymphocyte Count
  • Drug Administration Schedule
  • Drug Resistance, Microbial
  • Genotype
  • HIV Infections / drug therapy
  • HIV Infections / metabolism*
  • HIV Infections / virology
  • HIV Protease Inhibitors / pharmacokinetics*
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1 / drug effects
  • HIV-1 / genetics*
  • Humans
  • Indinavir / pharmacokinetics*
  • Indinavir / therapeutic use
  • Male
  • Multicenter Studies as Topic
  • Mutation
  • Plasma
  • Prospective Studies
  • RNA, Viral / blood
  • Saquinavir / pharmacokinetics*
  • Saquinavir / therapeutic use

Substances

  • HIV Protease Inhibitors
  • RNA, Viral
  • Indinavir
  • Saquinavir